Drug Profile
Bepotastine besilate - Mitsubishi Tanabe Pharma Corporation
Alternative Names: Bepotastine; Bepreve; Betotastine; Betotastine besilate; Talion; TAU-284Latest Information Update: 25 Jan 2021
Price :
$50
*
At a glance
- Originator Ube Industries
- Developer ISTA Pharmaceuticals; Mitsubishi Tanabe Pharma Corporation; Ube Industries
- Class Antiallergics; Antiasthmatics; Antihistamines; Antipruritics; Butyric acids; Chlorobenzenes; Eye disorder therapies; Piperidines; Pyridines; Skin disorder therapies; Small molecules
- Mechanism of Action Histamine H1 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Allergic conjunctivitis; Allergic rhinitis; Perennial allergic rhinitis; Pruritus; Urticaria
- No development reported Seasonal allergic rhinitis